Michael D. Becker serves as Executive at CYTOGEN CORP, where they oversee executive responsibilities. Since joining the company, Michael D. Becker has executed 7 insider transactions totaling $5.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 14, 2008 involved purchasing 35,000 shares valued at $3.5K.
Michael D. Becker currently holds 40,000 shares of CYTOGEN CORP (CYTO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael D. Becker has been a net buyer of CYTO stock. They have purchased $5.1K and sold $0 worth of shares.
Michael D. Becker's most recent insider trade was on Jan 14, 2008, when they purchased 35,000 shares at $0.10 per share.
Get notified when new Form 4 filings are submitted
| $0.11 |
| Discretionary |
| Jan 14, 2008 | VQPH | $500 | Purchase | 5,000 | $0.10 | Discretionary |
| Feb 20, 2007 | CYTO | $145.0K | Award | 58,000 | $2.50 | Discretionary |
| Dec 19, 2006 | CYTO | $48.0K | Award | 20,000 | $2.40 | Discretionary |
| Oct 17, 2006 | CYTO | $0 | Award | 15,000 | $N/A | Discretionary |
| Apr 4, 2006 | CYTO | $0 | Award | 20,000 | $N/A | Discretionary |